Jump to content

Octreotide (sandostatin) administered via insulin pump


Recommended Posts

Stumbled on this very interesting poster presentation from doctors in the UK:

https://www.endocrine-abstracts.org/ea/0031/eposters/ea0031p68_eposter.pdf

The patient could not tolerate the side effects from octreotide injections, so they tried her on an insulin pump delivery mode.

(It seems that octreotide had been delivered by pump for other conditions prior to this, possibly by the "endocrine team" mentioned in the study, so it was not that hard to parlay that experience over to someone with POTS who needed it.)

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...